Pacific Biosciences of California, Inc. Common Stock represents Pacific Biosciences of California, Inc., a life science technology company focused on designing, developing, and manufacturing advanced DNA sequencing solutions. The company’s products support genetic and genomic analysis for researchers and clinical scientists working on complex biological questions. Its portfolio centers on integrated sequencing platforms and related consumables and software used in laboratories that study genome structure, variation, and regulation. PacBio serves customers across academic research, biotechnology, pharmaceutical, and clinical markets, where high-accuracy sequencing tools are used to generate detailed genetic data. The company operates from Menlo Park, California, and is recognized for its role in the broader molecular diagnostics and genomics tools industry.
Website1305 O’Brien Drive
Menlo Park, CA, 94025
United States
Detailed price information for Palo Alto Networks (PANW-Q) from The Globe and Mail including charting and trades.
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 5.8% in the afternoon session after genomics provider Sampled announced a five-year contract worth up to $27.1 million from the U.S. Department of Veterans Affairs to support research using PacBio Revio sequencing systems.
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.62, marking a +2.53% move from the previous day.
Pacific Biosciences of California (NASDAQ:PACB) is maintaining its existing strategy while sharpening execution around clinical genomics, cost controls and the rollout of products designed to improve sequencing economics, Chief Executive Officer Mark Van Oene said during a Morgan Stanley discussion.
In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.38, indicating a +2.99% shift from the previous trading day.
Pacific Biosciences of California (PACB) closed at $1.27 in the latest trading session, marking a -1.55% move from the prior day.
Investors talking about PACB also mention
| # | Name | Attention |
|---|---|---|
| 1 | Illumina Inc.ILMN | 0%+0 |
| 2 | Bionano Genomics Inc.BNGO | 0%0 |
| 3 | Twist Bioscience CorporationTWST | 0%-0.02 |
| 4 | 10x Genomics Inc. Class A Common StockTXG | 0%-0.02 |
| 5 | ARK Genomic Revolution ETFARKG | 0.25%+0.09 |
| 6 | CRISPR Therapeutics AGCRSP | 0%0 |
| 7 | Beam Therapeutics IncBEAM | 0.02%+0.02 |
| 8 | Intellia Therapeutics, Inc.NTLA | 0%+0 |
| 9 | OMIC - Singular Genomics Systems, Inc. | —— |
| 10 | Editas Medicine, Inc.EDIT | 0%+0 |
What share of all stock conversation is about PACB?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% +0 | 0% 0 | 0% 0 |
Of the messages about PACB that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% 0 | 100% +33.33 | 96.88% +16.42 | 78.89% -7.83 | ||
| Bearish | 0% 0 | 0% -33.33 | 3.13% -16.42 | 21.11% +7.83 |
Of the messages about PACB that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | 100% | 82.61% | 76.47% | 31.99% | ||
| Technical Analysis | 0% | 17.39% | 17.65% | 21.33% | ||
| Earnings | 0% | 0% | 0% | 2.17% | ||
| Controversies | 0% | 0% | 5.88% | 0.12% | ||
| Analysts | 0% | 0% | 0% | 22.55% | ||
| Macro | 0% | 0% | 0% | 21.84% |
Of the messages about PACB, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 90% | 91.35% | 91.6% | 52.63% | ||
| Newcomers | 10% | 8.65% | 8.4% | 47.37% |